After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Avidity Biosciences Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Avidity Biosciences Inc is $3.42B. A total of 1.42 million shares were traded on the day, compared to an average of 1.53M shares.
In the most recent transaction, Gallagher Kathleen P. sold 5,875 shares of RNA for 32.40 per share on May 01 ’25. After the transaction, the Chief Program Officer now owns 50,554 company shares. In a previous transaction on May 01 ’25, KATHLEEN GALLAGHER bought 5,875 shares at 32.65 per share.
Among the insiders who sold shares, Gallagher Kathleen P. disposed of 5,875 shares on Apr 01 ’25 at a per-share price of $27.83. This resulted in the Chief Program Officer holding 50,554 shares of RNA after the transaction. In another insider transaction, Hughes Steven George sold 9,578 shares at $31.06 per share on Mar 20 ’25. Company shares held by the Chief Medical Officer now total 72,850.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RNA has a high of $56.00 and a low of $21.51.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RNA’s latest balance sheet shows that the firm has $405.54M in Cash & Short Term Investments as of fiscal 2021. There were $11.73M in debt and $29.66M in liabilities at the time. Its Book Value Per Share was $11.03, while its Total Shareholder’s Equity was $381.43M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RNA is Buy with a score of 4.86.
